General Announcement::Unaudited Financial Results for the Second Quarter and Half Year ended September 30, 2020

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
06-Nov-2020 23:53:59
Status
New
Announcement Sub Title
Unaudited Financial Results for the Second Quarter and Half Year ended September 30, 2020
Announcement Reference
SG201106OTHRGWTC
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Ltd.
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
06/11/2020 00:00:00
Description (Please provide a detailed description of the event in the box below)
Unaudited Financial Results (Standalone and Consolidated) for the Second Quarter and Half Year ended September 30, 2020

Attachments

SGX_RESULT_06.11.2020.pdf
Total size =2912K